These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8495635)

  • 41. Lovastatin: cholesterol-lowering agent.
    DiPalma JR
    Am Fam Physician; 1987 Dec; 36(6):189-92. PubMed ID: 3687679
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression.
    Baldassarre D; Franceschini G; Peruzzotti G; Brusoni B; Sirtori CR
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):784-9. PubMed ID: 9436818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
    Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
    Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
    Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM
    Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.
    Lane JT; Subbaiah PV; Otto ME; Bagdade JD
    J Lab Clin Med; 1991 Aug; 118(2):120-8. PubMed ID: 1856575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-dependent change in the effect of probucol in subjects with elevated cholesterol.
    Fujimura A; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1992; 43(3):299-301. PubMed ID: 1425896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors predictive of marked decrease in HDL-C by probucol treatment.
    Yashiro A; Nakashima Y; Segawa J; Kawashima T; Kuroiwa A
    Artery; 1990; 18(1):16-31. PubMed ID: 2085284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Schwartzkopff W; Bimmermann A; Schleicher J
    Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressive symptoms in hypercholesterolaemic patients treated with pravastatin.
    Lechleitner M; Hoppichler F; Konwalinka G; Patsch JR; Braunsteiner H
    Lancet; 1992 Oct; 340(8824):910. PubMed ID: 1357315
    [No Abstract]   [Full Text] [Related]  

  • 51. Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients.
    Trapé J; Morales C; Molina R; Filella X; Marcos JM; Salinas R; Franquesa J
    Scand J Clin Lab Invest; 2006; 66(3):261-7. PubMed ID: 16714254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA; Krehbiel P; Chernoff SB
    Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study.
    Jones PH; Farmer JA; Cressman MD; McKenney JM; Wright JT; Proctor JD; Berkson DM; Farnham DJ; Wolfson PM; Colfer HT
    Clin Cardiol; 1991 Feb; 14(2):146-51. PubMed ID: 1904333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.
    Carlsson CM; Papcke-Benson K; Carnes M; McBride PE; Stein JH
    Drugs Aging; 2002; 19(10):793-805. PubMed ID: 12390056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites.
    Ismail F; Corder CN; Epstein S; Barbi G; Thomas S
    Clin Ther; 1990; 12(5):427-30. PubMed ID: 2125243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New possibilities of correction of hypercholesterolemia in patients with diabetes mellitus].
    Pan'kiv VI
    Lik Sprava; 2014; (5-6):56-67. PubMed ID: 25906648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients].
    Zanella MT; Plavinik F; Zampieri M; Peres RB; Ribeiro AB
    Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probucol versus eptastatin in hypercholesterolaemic diabetics.
    Yoshino G; Kazumi T; Uenoyama R; Inui A; Kasama T; Iwatani I; Iwai M; Yokono K; Otsuki M; Baba S
    Lancet; 1986 Sep; 2(8509):740-1. PubMed ID: 2876200
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A; Gelfand J; Blum C; Appel GB
    Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pravastatin in dyslipidaemic patients with and without hypertension.
    Tsukiyama H; Otsuka K
    J Hypertens Suppl; 1993 Dec; 11(5):S346-7. PubMed ID: 8158416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.